Search Results 251-260 of 16311 for Alirocumab
A Phase 2/3 Study On The Efficacy And Safety Of Mangaciclanol For ContrastEnhanced MRI Of CNS Or Body In Adult Patients · Overview · Participation eligibility.
The purpose of this study is to evaluate the short-term outcomes and the quality of life (QOL) after cholecystectomy and hepatic artery infusion pump placement ...
Your doctor will perform a test to check for the ALK gene before you use this medicine. Alectinib belongs to the group of medicines called antineoplastics ( ...
The purpose of this study is to compare the efficacy and safety of eflornithine in combination with lomustine, compared to lomustine taken alone, in treating ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
Description. Lacosamide is used to treat partial-onset seizures. It is also used with other medicines to treat primary generalized tonic-clonic seizures.
The purpose of this study is to evaluate the safety and drug/body interactions of ABBV-085, and to determine the recommended future study dose (alone or in ...
PARPs are proteins that help repair DNA mutations. PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and ...
RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the signaling molecules needed for cell growth. Monoclonal antibodies, such as ...
Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!